Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs

D Terentes-Printzios, N Ioakeimidis, K Rokkas… - Nature Reviews …, 2022 - nature.com
Sexual health has a fundamental role in overall health and well-being, and a healthy and
dynamic sex life can make an important contribution to a good quality of life. Sexual …

The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis

BP Gupta, MH Murad, MM Clifton… - Archives of internal …, 2011 - jamanetwork.com
Background Erectile dysfunction (ED) shares similar modifiable risks factors with coronary
artery disease (CAD). Lifestyle modification that targets CAD risk factors may also lead to …

The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease

A Nehra, G Jackson, M Miner, KL Billups… - Mayo Clinic …, 2012 - Elsevier
Abstract The Princeton Consensus (Expert Panel) Conference is a multispecialty
collaborative tradition dedicated to optimizing sexual function and preserving cardiovascular …

Sexual dysfunction, cardiovascular risk and effects of pharmacotherapy

KP Imprialos, K Stavropoulos… - Current vascular …, 2018 - ingentaconnect.com
Background: Sexual dysfunction affects millions of people with an increasing prevalence,
worldwide. The pathophysiology of the disease shares several similarities with …

The effect of statins on erectile dysfunction: a meta‐analysis of randomized trials

JB Kostis, JM Dobrzynski - The journal of sexual medicine, 2014 - Elsevier
Introduction Erectile dysfunction (ED) is common in older men, especially those with
comorbidities such as diabetes and atherosclerotic disease, conditions where statins are …

A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice

MPJ Nicolai, SS Liem, S Both, RCM Pelger… - Netherlands Heart …, 2014 - Springer
Several antihypertensive drugs, such as diuretics and β-blockers, can negatively affect
sexual function, leading to diminished quality of life and often to noncompliance with the …

The role of statins in erectile dysfunction: a systematic review and meta-analysis

X Cai, Y Tian, T Wu, CX Cao, SY Bu… - Asian Journal of …, 2014 - journals.lww.com
To evaluate the effect of statins for erectile dysfunction (ED), a systematic review of the
literature was conducted in the Cochrane Library, Embase and PubMed from the inception …

Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction

D Neves - Free radical research, 2013 - Taylor & Francis
Reactive derivatives of non-enzymatic glucose-protein condensation reactions integrate a
heterogeneous group of irreversible adducts called advanced glycation end-products …

Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management

RE Scranton, I Goldstein… - The journal of sexual …, 2013 - academic.oup.com
Introduction Optimal pharmacologic management of diseases comorbid with erectile
dysfunction (ED), such as cardiovascular disease, depression, diabetes, dyslipidemia …

Non-invasive management options for erectile dysfunction when a phosphodiesterase type 5 inhibitor fails

M Lee, R Sharifi - Drugs & aging, 2018 - Springer
Phosphodiesterase type 5 inhibitors (PDE5Is) are the drug of choice for medical
management of erectile dysfunction (ED). On-demand PDE5Is have an overall efficacy of 60 …